CINECA IRIS Institutional Research Information System

DANESI, ROMANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.153
EU - Europa 12.010
AS - Asia 4.805
AF - Africa 431
SA - Sud America 64
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 54.529
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.355
IT - Italia 4.193
SE - Svezia 2.331
CN - Cina 2.273
BG - Bulgaria 1.377
DE - Germania 1.207
SG - Singapore 888
CA - Canada 781
GB - Regno Unito 698
UA - Ucraina 600
TR - Turchia 576
VN - Vietnam 540
FI - Finlandia 511
CI - Costa d'Avorio 258
CH - Svizzera 221
HK - Hong Kong 164
IN - India 152
FR - Francia 150
RU - Federazione Russa 149
AT - Austria 133
BE - Belgio 111
GR - Grecia 92
SN - Senegal 63
NG - Nigeria 62
PL - Polonia 47
NL - Olanda 45
AU - Australia 41
JP - Giappone 40
BR - Brasile 31
ES - Italia 30
KR - Corea 27
IR - Iran 23
ID - Indonesia 20
TW - Taiwan 20
IE - Irlanda 18
EG - Egitto 17
RO - Romania 17
CZ - Repubblica Ceca 16
EU - Europa 15
DK - Danimarca 14
MX - Messico 14
BJ - Benin 13
CO - Colombia 13
HU - Ungheria 13
MY - Malesia 12
TH - Thailandia 12
PH - Filippine 11
JO - Giordania 8
NZ - Nuova Zelanda 8
CL - Cile 7
DZ - Algeria 7
IL - Israele 7
RS - Serbia 7
SA - Arabia Saudita 7
HR - Croazia 6
PT - Portogallo 6
AR - Argentina 5
EC - Ecuador 4
IQ - Iraq 4
LK - Sri Lanka 4
NO - Norvegia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
BF - Burkina Faso 3
LT - Lituania 3
LU - Lussemburgo 3
DO - Repubblica Dominicana 2
LV - Lettonia 2
MA - Marocco 2
PE - Perù 2
TG - Togo 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
UY - Uruguay 1
Totale 54.529
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.733
Fairfield 4.242
Ann Arbor 4.203
Houston 3.982
Chandler 2.443
Ashburn 2.102
Seattle 1.777
Wilmington 1.507
Cambridge 1.448
Sofia 1.376
Serra 1.075
Milan 982
New York 853
Beijing 783
Jacksonville 770
Ottawa 734
Boardman 682
Princeton 620
Lawrence 562
Izmir 547
Medford 506
Nanjing 449
Singapore 373
Dearborn 361
Des Moines 333
Abidjan 258
Dong Ket 236
San Diego 219
Bern 207
Florence 195
Pisa 193
Nanchang 174
Boulder 159
London 149
Hong Kong 148
Redwood City 144
Vienna 130
Falls Church 129
Jüchen 126
Washington 124
Frankfurt am Main 118
Kunming 112
Brussels 101
Rome 96
Ogden 90
Bremen 89
Hebei 86
Changsha 73
Los Angeles 73
Shenyang 73
Norwalk 65
Dakar 63
Düsseldorf 63
Lagos 62
Hefei 58
Jiaxing 57
Pune 55
Tianjin 52
Dallas 45
Chicago 42
Warsaw 38
Turin 37
Nürnberg 36
Auburn Hills 35
Marseille 34
Seacroft 34
Guangzhou 33
Indiana 33
Lancaster 33
Jinan 32
Phoenix 28
Helsinki 27
Orange 27
Shanghai 26
Detroit 25
Toronto 24
San Francisco 23
Lanzhou 22
Grafing 21
Hangzhou 20
Rho 18
Livorno 17
Verona 16
Changchun 15
Chengdu 15
Tappahannock 15
Zhengzhou 15
Kocaeli 14
Cotonou 13
Edinburgh 13
Kilburn 13
Leawood 13
East Setauket 12
Bologna 11
Budapest 11
Chiesina Uzzanese 11
Chongqing 11
Naples 11
Amsterdam 10
Jakarta 10
Totale 43.359
Salva come PNG Salva come JPEG
Nome #
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer 379
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity 304
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 240
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer 210
A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma 209
Determination of mitotane and principal metabolite by a simple HPLC-UV method and its validation in human plasma sample 198
Exogenous doxorubicinol induces cardiotoxic effects in rats 194
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration 192
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 188
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 185
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. 170
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 170
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 166
In vitro studies on gemcitabine combinations with other antiblastics 165
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 163
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 163
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life 162
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 161
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 159
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer 158
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 158
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients 157
Pharmacogenetics in Oncology 155
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 155
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. 153
Embryonic stem cell pathways and chemotherapy response: an unexplored route. 151
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 151
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors 150
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 150
Cancer stem cell epigenetics and chemoresistance 149
5-Fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer 149
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 147
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer 147
Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel 146
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 146
Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart 145
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 145
Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients 145
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity 145
Doxorubicin cardiotoxicity in the dog: A morphofunctional study 144
Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. 144
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer 143
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 142
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 142
null 142
Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization 141
The effects of the somatostatin analog octreotide on angiogenesis in vitro 140
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors 140
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. 140
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients 139
Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors 138
The emerging role of histone lysine demethylases in prostate cancer. 138
Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications 138
The effect of rhGM-CSF on the proliferation of osteogenic sarcoma cells 137
Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment 137
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. 137
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 137
A pilot study of suramin in the treatment of metastatic renal cell carcinoma 136
Clinical and experimental evidence of inhibition of testosterone production by suramin 136
Genetic analysis of cytidine deaminase (CDA) for the prediction of response to chemotherapy and survival in advanced non-small-cell lung cancer (NSCLC) patients treated with gemcitabine 135
Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer 135
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 135
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference Mass Spectrometry 135
4'-Epidoxorubicin cardiotoxicity 134
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction 134
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 134
DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis. 134
Chronic administration of suramin induces neurotoxicity in rats 133
Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines 133
Efficacy and safety of basiliximab in kidney transplantation 132
Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin 132
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw 132
Suramin, a novel antitumor compound 131
Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiforme 131
Exploratory analysis of circulating pro-and anti-angiogenic factors in metastatic colorectal cancer (MCRC) patients, treated with GONO-folfoxiri plus bevacizumab (BV) 131
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines 131
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells 131
Histone lysine demethylases in breast cancer. 131
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 131
Doxorubicin modifies plasma levels of immunoreactive atrial natriuretic factor 130
CYP2D6 polymorphisms and the impact on tamoxifen therapy 130
Durable complete response to frontline docetaxel in an advanced prostate cancer patient with favourable CYP1B1 isoforms: suggestion for changing paradigms? 130
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 130
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma 130
The pharmacological bases of the antiangiogenic activity of paclitaxel 129
Methods: For studying pharmacogenetic profiles of combination chemotherapeutic drugs 129
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 129
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 129
General and cardiac toxicity of adriamycinol in rats 128
Impact of locoregional approaches to liver metastases in patients with colorectal cancer 128
Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells 128
Administration interval and daptomycin toxicity: a case report of rhabdomyolysis 128
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients 128
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer. 128
Circulating amphiregulin (AR) plasma levels as surrogate pharmacodynamic markers of EGFR inhibition with cetuximab in metastatic colorectal cancer (MCRC) patients 127
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer 127
null 127
Gender, MGMT methylation, and levetiracetam plasma levels correlate with survival benefit in glioblastoma patients treated with adjuvant temozolomide: results from a non-interventional retrospective clinical study 127
Exploratory analysis of circulating pro-and anti-angiogenic factors in metastatic colorectal cancer (MCRC) patients, treated with GONO-folfoxiri plus bevacizumab (BV) 126
Periodontal tissue disposition of azithromycin 126
Totale 14.920
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.953
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.028 0 0 0 764 1.076 1.356 1.280 918 1.072 638 718 206
2020/20215.141 416 359 366 249 542 252 335 612 506 438 333 733
2021/20226.446 150 395 247 391 1.027 1.006 228 332 262 244 347 1.817
2022/20237.336 1.005 840 474 693 833 1.022 61 565 1.253 48 478 64
2023/20245.397 658 583 710 326 747 1.031 150 263 91 111 183 544
2024/20251.032 112 680 122 118 0 0 0 0 0 0 0 0
Totale 55.621